Investor Stock List
Ranked #1,903 of 8,699 institutional investors

ARCH Venture Management, LLC

Chicago, IL

$1.42B
US stock portfolio at live prices · today +$1.1M (+0.08%)
Market closed. Prices as of Nov 20, 8:41 AM ET
Value at quarter end (Q3 2026)
$1.61B
Change from Q2 2026
+$513.1M (+46.63%)
Positions
17 · 6 new, 1 sold out
Filed
Nov 16, 2026

Holdings

Q3 2026 13F, live prices
KARD 13.3%PBLS 12.5%MAZE 9.43%SRRK 8.34%SPTX 8.14%
StockSharesValue, live% of portfoliovs Q2 2026
KARD Kardigan, Inc.15,042,036$188M13.3%New
PBLS Parabilis Medicines, Inc.6,412,780$177M12.5%Unchanged
MAZE Maze Therapeutics, Inc.4,120,053$134M9.43%Unchanged
SRRK Scholar Rock Holding Corporation2,345,711$118M8.34%New
SPTX Seaport Therapeutics, Inc.6,294,951$115M8.14%Unchanged
VIR Vir Biotechnology, Inc.12,694,163$113M7.95%Unchanged
ERAS Erasca, Inc.7,091,557$101M7.12%Unchanged
BEAM Beam Therapeutics Inc.4,540,132$95.1M6.71%Unchanged
RAPP Rapport Therapeutics, Inc.3,728,738$88.0M6.21%Unchanged
SANA Sana Biotechnology, Inc.45,860,681$79.8M5.63%New
PRME Prime Medicine, Inc.18,486,894$71.0M5.01%New
MASS 908 Devices Inc.5,725,045$53.6M3.79%New
LYEL Lyell Immunopharma, Inc.3,247,162$44.1M3.11%Unchanged
GENB Generate Biomedicines, Inc.1,944,426$20.2M1.42%Unchanged
NMRA Neumora Therapeutics, Inc.33,847,838$11.7M0.83%New
BOLD Boundless Bio, Inc.2,694,095$6.4M0.45%Unchanged
GOSS Gossamer Bio, Inc.100,698$1.1M<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
TXG 10x Genomics, Inc.217,834$12.5M